2/12
11:09 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
11:09 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
10:57 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
2/12
10:57 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
2/12
10:47 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
10:47 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
08:36 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
08:00 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/12
08:00 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00.
Low
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00.
2/12
07:29 am
sage
Rating for SAGE
Low
Report
Rating for SAGE
2/12
07:29 am
sage
Rating for SAGE
Low
Report
Rating for SAGE